Přejít k obsahu
Merck
Všechny fotografie(2)

Hlavní dokumenty

Zobrazit celou dokumentaci

226351

Sigma-Aldrich

N-Hydroxymaleimide

97%, for peptide synthesis

Synonyma:

1-Hydroxypyrrole-2,5-dione

Přihlásitk zobrazení cen stanovených pro organizaci a smluvních cen
Všechny fotografie(2)

About This Item

Empirický vzorec (Hillův zápis):
C4H3NO3
Číslo CAS:
4814-74-8
Molekulová hmotnost:
113.07
Beilstein/REAXYS Number:
1524594
EC Number:
225-385-4
MDL number:
MFCD00005501
UNSPSC Code:
12352005
PubChem Substance ID:
24853562
NACRES:
NA.22

Název produktu

N-Hydroxymaleimide, 97%

assay

97%

form

solid

reaction suitability

reaction type: Addition Reactions

mp

130-133 °C (dec.) (lit.)

application(s)

peptide synthesis

functional group

imide
maleimide

SMILES string

ON1C(=O)C=CC1=O

InChI

1S/C4H3NO3/c6-3-1-2-4(7)5(3)8/h1-2,8H

InChI key

BUXKULRFRATXSI-UHFFFAOYSA-N

Hledáte podobné produkty? Navštivte Průvodce porovnáváním produktů

Související kategorie

General description

N-Hydroxymaleimide (NHMI) is an organic compound that is widely used as an oxidizing agent in organic synthesis. It is frequently used to selectively oxidize thiols to disulfides and in the synthesis of α, β-unsaturated carbonyl compounds. It can also act as a Michael acceptor and is used in the synthesis of peptides and proteins.

Application

N-Hydroxymaleimide can be used as an oxidant to generate N-hydroxy anilines in situ, which serve as key intermediates in the selective coupling reaction of N-substituted anilines with hydroxylamine derivatives, for the efficient synthesis of aromatic oximes.

pictograms

Corrosion
GHS05

signalword

Danger

hcodes

H314

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B

Storage Class

8A - Combustible corrosive hazardous materials

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Vyberte jednu z posledních verzí:

Osvědčení o analýze (COA)

Lot/Batch Number
BCCC3003
BCBW0273
BCBH2786V
1451856V
1451856

Nevidíte správnou verzi?

Potřebujete-li konkrétní verzi, můžete vyhledat daný certifikát podle čísla dávky nebo čísla šarže.

Vyhledat COA

Již tento produkt vlastníte?

Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.

Navštívit knihovnu dokumentů

Zákazníci si také prohlíželi

Slide 1 of 3

1 of 3

N-Cyclohexylmaleimide 97%

Sigma-Aldrich

381543

N-Cyclohexylmaleimide

N-tert-Butylmaleimide 97%

Sigma-Aldrich

386421

N-tert-Butylmaleimide

N-Benzylmaleimide 99%

Sigma-Aldrich

408018

N-Benzylmaleimide

Minye Yang et al.
Nanoscale, 10(33), 15865-15874 (2018-08-15)
The detection of mycotoxins in food is urgently needed because they pose a significant threat to public health. In this study, we developed a quantitative detection platform for mycotoxins by integrating multicolor upconversion nanoparticle barcode technology with fluorescence image processing
Jamerson Carneiro de Oliveira et al.
Molecules (Basel, Switzerland), 25(2) (2020-01-16)
The study of Diels-Alder reactions in materials science is of increasing interest. The main reason for that is the potential thermoreversibility of the reaction. Aiming to predict the behavior of a material modified with maleimido and furyl moieties, 1H NMR
Yusuke Hibi et al.
Nature communications, 7, 11064-11064 (2016-03-22)
There is a growing interest in sequence-controlled polymers toward advanced functional materials. However, control of side-chain order for vinyl polymers has been lacking feasibility in the field of polymer synthesis because of the inherent feature of chain-growth propagation. Here we
Moon Soo Gil et al.
Journal of controlled release : official journal of the Controlled Release Society, 267, 119-132 (2017-04-17)
Biological drugs are exquisitely tailored components offering the advantages of high specificity and efficacy that are considered safe for treating diseases. Nevertheless, the effectiveness of biological drugs is limited by their inherent short biological half-life and poor stability in vivo.
Jinhwan Cho et al.
Journal of controlled release : official journal of the Controlled Release Society, 324, 532-544 (2020-05-27)
Therapeutic proteins are attractive candidates for the treatment of human diseases. However, their short half-life often limits their clinical application. To overcome this problem, injectable hydrogels have been developed as depots for controlled release of therapeutic proteins, but these systems

Náš tým vědeckých pracovníků má zkušenosti ve všech oblastech výzkumu, včetně přírodních věd, materiálových věd, chemické syntézy, chromatografie, analytiky a mnoha dalších..

Obraťte se na technický servis.